Phosphotyrosine phosphatases in cancer diagnostic and treatment

María M Tiscornia1, Mario A Riera, María A Lorenzati

  • 1Laboratory of Molecular Biotechnology, Facultad de Ciencias Exactas Químicas y Naturales, Universidad Nacional de Misiones, Av. Mariano Moreno 1375, Posadas, Misiones, Argentina. pdr_dario@yahoo.com

Insights

Post-translational modification regulates cellular functions through protein phosphorylation and dephosphorylation. Understanding these mechanisms, particularly phosphotyrosine phosphatases (PTPs), is crucial for cancer diagnosis and therapy.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cellular Biology

Background:

  • Post-translational modifications, including phosphorylation and dephosphorylation, are vital for regulating cellular processes like growth, development, and communication.
  • The phosphotyrosine phosphatases (PTPs) signaling pathway is implicated in various biological states, including disease and aging.
  • Current research and patents focus on PTPs for cancer diagnosis, prognosis, and treatment strategies.

Purpose of the Study:

  • To highlight the significance of protein post-translational modifications in cellular regulation.
  • To underscore the role of phosphotyrosine phosphatases (PTPs) in cancer development.
  • To emphasize the need for deeper understanding of PTPs' molecular mechanisms for therapeutic advancements.

Main Methods:

  • Review of current literature and patent landscape concerning PTPs.
  • Discussion of advanced diagnostic techniques, including transcriptomic and proteomic approaches.
  • Exploration of emerging therapeutic strategies involving antibodies and inhibitors targeting PTPs.

Main Results:

  • Protein modification is a fundamental mechanism controlling cellular activities.
  • PTPs are critical players in signaling pathways relevant to cancer.
  • New diagnostic and therapeutic approaches are emerging, driven by transcriptomic and proteomic data.

Conclusions:

  • A comprehensive understanding of PTPs' molecular mechanisms is essential for developing effective cancer therapies.
  • The integration of transcriptomic and proteomic data is advancing cancer diagnostics and treatment.
  • Targeting PTPs represents a promising avenue for novel cancer therapeutics.

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...